Facilitating collaborations to develop combination investigational cancer therapies workshop summary

"Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in cancer. Combining investigational products early in their development is thought to be a promising strategy for identifying effective...

Full description

Bibliographic Details
Main Author: Institute of Medicine (U.S.) (-)
Corporate Authors: National Cancer Policy Forum (U.S.), Institute of Medicine (U.S.). Board on Health Care Services
Other Authors: Patlak, Margie (-), Balogh, Erin, Nass, Sharyl J.
Format: eBook
Language:Inglés
Published: Washington, D.C. : National Academies Press 2012.
Edition:1st ed
Subjects:
See on Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009622257406719
Table of Contents:
  • Introduction
  • Why Combinations and Collaborations Are Necessary
  • Scientific Challenges in Developing Investigational Combination Therapies
  • Overcoming Cultural Challenges to Collaborations Legal Issues in Collaborations
  • Financial Challenges
  • Regulatory Issues
  • Codevelopment of Therapies for HIV as a Model
  • Examples of Collaborations Relevant to Cancer
  • Wrapping Up
  • Appendix A: Examples of Collaborations
  • Appendix B: Workshop Agenda
  • References
  • Acronyms.